Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The antiphospholipid syndrome

P L Edelman1

  • 1Department of Obstetrics and Gynecology, Bichat Hospital, Paris, France.

Current Opinion in Obstetrics & Gynecology
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Antiphospholipid syndrome in obstetrics causes maternofetal pathology via thrombosis. Preventive therapy using aspirin, heparin, or corticosteroids is effective for managing this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Joint impairment and self-reported disability in elderly persons.

Journal of gerontology·1993
Same author

Impact of long-term home care on mortality, functional status, and unmet needs.

Health services research·1988
Same author

Impact of long-term home care on hospital and nursing home use and cost.

Health services research·1987
See all related articles

Area of Science:

  • Obstetrics
  • Immunology
  • Pathology

Background:

  • Antiphospholipid syndrome (APS) is a significant cause of maternofetal pathology.
  • It is characterized by systemic and intraplacental thrombosis.
  • Key pro-coagulant antibodies include lupus anticoagulant and anticardiolipin antibody.

Purpose of the Study:

  • To highlight antiphospholipid syndrome as a model for maternofetal pathology.
  • To discuss the known pro-coagulant antibodies involved.
  • To outline current therapeutic strategies.

Main Methods:

  • Review of existing literature on antiphospholipid syndrome in obstetrics.
  • Identification of key antibodies and their role in thrombosis.
  • Analysis of established therapeutic interventions.

Related Experiment Videos

Main Results:

  • Antiphospholipid syndrome leads to maternofetal pathology through thrombosis.
  • Lupus anticoagulant and anticardiolipin antibody are identified as critical.
  • Preventive therapy demonstrates efficiency.

Conclusions:

  • Antiphospholipid syndrome is a crucial area of study in obstetric pathology.
  • Effective management relies on careful selection of aspirin, heparin, and corticosteroids.
  • Therapy is primarily preventive and efficient.